{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T23:02:01Z","timestamp":1784847721301,"version":"3.55.0"},"reference-count":41,"publisher":"Georg Thieme Verlag KG","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Monbl Augenheilkd"],"DOI":"10.1055\/a-2878-5961","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T22:35:38Z","timestamp":1784846138000},"source":"Crossref","is-referenced-by-count":0,"title":["Seltene vaskul\u00e4re Erkrankungen der Netzhaut \u2013 Teil 2"],"prefix":"10.1055","author":[{"given":"Kristina","family":"Pfau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albrecht","family":"Lommatzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Sch\u00fcler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5221-4631","authenticated-orcid":false,"given":"Ulrich","family":"Kellner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1055\/a-2129-1307","article-title":"[Less frequent vascular disorders of the retina \u2013 Part 1]","author":"H Heimann","year":"2023","journal-title":"Klin Monbl Augenheilkd"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fopht.2025.1727063","article-title":"Diagnostic challenges in high myopia: identification of sight-threatening complications and the role of artificial intelligence","volume":"5","author":"S Zhang","year":"2025","journal-title":"Front Ophthalmol (Lausanne)"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1038\/s41433-024-03183-1","article-title":"Lacquer cracks in pathological myopia: a clinical review","volume":"38","author":"K Neelam","year":"2024","journal-title":"Eye (Lond)"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40662-025-00450-4","article-title":"Myopic choroidal neovascularization with dilated choroid vessels is prone to progression into subretinal fibrosis following anti-vascular endothelial growth factor therapy: a retrospective study","volume":"12","author":"X She","year":"2025","journal-title":"Eye Vis (Lond)"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1007\/s00417-023-06320-w","article-title":"Differential diagnosis of myopic choroidal neovascularization (mCNV): insights from multimodal imaging and treatment implications","volume":"262","author":"A Feo","year":"2024","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1007\/s00417-023-06271-2","article-title":"Treatment of myopic choroidal neovascularization: a network meta-analysis and review","volume":"262","author":"L Glachs","year":"2024","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1097\/IAE.0000000000004605","article-title":"Factors influencing the number of anti-VEGF injections in myopic choroidal neovascularization: A multicenter study","volume":"45","author":"N Castellino","year":"2025","journal-title":"Retina"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.2147\/OPTH.S461515","article-title":"Chorioretinal atrophic lesions evolution in patients with quiescentm choroidal neovascularization followed for more than 10 years","volume":"18","author":"AM Ferreira","year":"2024","journal-title":"Clin Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s00417-025-07042-x","article-title":"Idiopathic macular telangiectasia type 1: Clinical, multimodal imaging features and response to treatment","volume":"264","author":"A Carnevali","year":"2026","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ajo.2025.10.014","article-title":"International Consensuses and Guidelines on Diagnosing and Managing Coats Disease by the Academia Retina Internationalis (ARI), the Asia-Pacific Vitreo-retina Society (APVRS), and the Academy of the Asia-Pacific Professors of Ophthalmology (AAPPO)","volume":"282","author":"M Mahesh","year":"2026","journal-title":"Am J Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.ophtha.2025.11.008","article-title":"Long-term progression of ellipsoid zone loss and associated features on OCT in macular telangiectasia type 2","volume":"133","author":"K Raming","year":"2026","journal-title":"Ophthalmology"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/IAE.0000000000004681","article-title":"Frequency of misdiagnoses and associated risk factors in macular telangiectasia type 2","volume":"46","author":"K Raming","year":"2026","journal-title":"Retina"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2025.101401","article-title":"Clinical histopathology and pathogenesis of macular telangiectasia type 2","volume":"110","author":"DP Ntentakis","year":"2026","journal-title":"Prog Retin Eye Res"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1097\/IAE.0000000000004052","article-title":"Methylation-associated pathways in macular telangiectasia type 2 and ophthalmologic findings in patients with genetic methylation disorders","volume":"44","author":"L Pauleikhoff","year":"2024","journal-title":"Retina"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2022.100261","article-title":"Macular telangiectasia type 2: A classification system using multimodal imaging MacTel Project Report Number 10","volume":"3","author":"EY Chew","year":"2023","journal-title":"Ophthalmol Sci"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.3390\/jcm15041327","article-title":"Macular telangiectasia type 2: The role of optical coherence tomography and management options","volume":"15","author":"DI Beuran","year":"2026","journal-title":"J Clin Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.survophthal.2023.03.003","article-title":"Foveal photoreceptor disruption in ocular diseases: An optical coherence tomography-based differential diagnosis","volume":"68","author":"SR Singh","year":"2023","journal-title":"Surv Ophthalmol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2400481","article-title":"Cell-based ciliary neurotrophic factor therapy for macular telangiectasia type 2","volume":"4","author":"EY Chew","year":"2025","journal-title":"NEJM Evid"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1038\/s41598-025-32239-9","article-title":"Clinical characteristics, imaging features, and treatment outcomes of macular telangiectasia type 2: a comprehensive meta-analysis","volume":"16","author":"M He","year":"2026","journal-title":"Sci Rep"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000543771","article-title":"Anti-vascular endothelial growth factor treatment outcomes in macular telangiectasia: A systematic review","volume":"248","author":"A Sriranganathan","year":"2025","journal-title":"Ophthalmologica"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2025.103440","article-title":"REACT-PXE: a consensus on diagnosis and future research concerning pseudoxanthoma elasticum (PXE)","volume":"153","author":"L Martin","year":"2026","journal-title":"Ann Dermatol Venereol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2024.101274","article-title":"Pseudoxanthoma elasticum \u2013 Genetics, pathophysiology, and clinical presentation","volume":"102","author":"K Pfau","year":"2024","journal-title":"Prog Retin Eye Res"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s00347-025-02261-3","article-title":"[Ocular alterations in pseudoxanthoma elasticum : The eye as a window to diagnosing a systemic disease]","volume":"122","author":"K Raming","year":"2025","journal-title":"Ophthalmologie"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ajo.2024.03.026","article-title":"Anti-VEGF treatment for secondary neovascularization in pseudoxanthoma elasticum \u2013 age of onset, treatment frequency, and visual outcome","volume":"265","author":"K Raming","year":"2024","journal-title":"Am J Ophthalmol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1001\/jamaophthalmol.2025.4031","article-title":"High-resolution optical coherence tomography correlates of peau d\u2019orange in pseudoxanthoma elasticum","volume":"143","author":"J Meinke","year":"2025","journal-title":"JAMA Ophthalmol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1167\/iovs.66.2.17","article-title":"Topography of slowed dark adaptation in pseudoxanthoma elasticum: PROPXE Study Report 1","volume":"66","author":"K Pfau","year":"2025","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1136\/bjophthalmol-2014-305884","article-title":"Long-term, therapy-related visual outcome of 49 cases with retinal arterial macroaneurysm: a case series and literature review","volume":"99","author":"S Koinzer","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/IAE.0000000000003725","article-title":"Impact of macular intraretinal hemorrhage and macular hole on the visual prognosis of submacular hemorrhage due to retinal arterial macroaneurysm rupture","volume":"43","author":"S Doi","year":"2023","journal-title":"Retina"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1007\/s00417-016-3388-9","article-title":"Angiographic features and disease outcomes of symptomatic retinal arterial macroaneurysms","volume":"254","author":"EL Hughes","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40942-018-0133-z","article-title":"Direct navigated laser photocoagulation as primary treatment for retinal arterial macroaneurysms","volume":"4","author":"DS Maltsev","year":"2018","journal-title":"Int J Retina Vitreous"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12093291","article-title":"Removal of sub-internal limiting membrane hemorrhage secondary to retinal arterial macroaneurysm rupture: internal limiting membrane non-peeling technique","volume":"12","author":"A Kimura","year":"2023","journal-title":"J Clin Med"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1097\/IAE.0000000000004799","article-title":"Vitrectomy and subretinal tPA injection for subretinal hemorrhage secondary to retinal arterial macroaneurysm: A multicenter study","volume":"46","author":"MO Ok","year":"2026","journal-title":"Retina"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"763","DOI":"10.4103\/ijo.IJO_841_19","article-title":"Coats disease: An overview of classification, management and outcomes","volume":"67","author":"M Sen","year":"2019","journal-title":"Indian J Ophthalmol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1111\/aos.17554","article-title":"Long-term outcome of Coats\u2019 disease: Implications for the classification of foveal vascular pathologies","volume":"104","author":"C Brockmann","year":"2026","journal-title":"Acta Ophthalmol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.788001","article-title":"Updating understanding of macular microvascular abnormalities and their correlations with the characteristics and progression of macular edema or exudation in Coats\u2019 disease","volume":"9","author":"J Zhang","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.2174\/1874364101610010022","article-title":"Coats\u2019 Disease: Very long-term outcome after early stage conventional treatment","volume":"10","author":"S Perrone","year":"2016","journal-title":"Open Ophthalmol J"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1186\/s12886-025-04236-z","article-title":"Idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome: a comprehensive literature review of a rare retinal vasculopathy","volume":"25","author":"H Asaad","year":"2025","journal-title":"BMC Ophthalmol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.jcjo.2017.12.015","article-title":"Long-term outcomes in a series of idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome","volume":"53","author":"E Massicotte","year":"2018","journal-title":"Can J Ophthalmol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1177\/25158414211070880","article-title":"Comprehensive overview of IRVAN syndrome: a structured review of case reports and case series","volume":"14","author":"H Ali Khan","year":"2022","journal-title":"Ther Adv Ophthalmol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-026-04692-1","article-title":"Adalimumab in the management of refractory idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome: a case report and literature review","volume":"26","author":"AB Qadan","year":"2026","journal-title":"BMC Ophthalmol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2025.2530134","article-title":"Long-term efficacy of infliximab therapy in idiopathic retinal vasculitis, aneurysms and neuroretinitis (IRVAN) syndrome","author":"RA Mandura","year":"2025","journal-title":"Ocul Immunol Inflamm"}],"container-title":["Klinische Monatsbl\u00e4tter f\u00fcr Augenheilkunde"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2878-5961.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T22:35:39Z","timestamp":1784846139000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2878-5961"}},"subtitle":["Less Frequent Vascular Disorders of the Retina \u2013 Part 2"],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":41,"URL":"https:\/\/doi.org\/10.1055\/a-2878-5961","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0023-2165","1439-3999"],"issn-type":[{"value":"0023-2165","type":"print"},{"value":"1439-3999","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]}}}